Aridis Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
2 Contracts & Agreements
- Description of the Registrant's Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 8, 2020)
- Amendment No. 1 to the Agreement between the Registrant and the Cystic Fibrosis Foundation Therapeutics, Inc., effective November 26, 2018 (Filed With SEC on March 28, 2019)
